![](https://investorshub.advfn.com/uicon/613762.png?cb=1495247035)
Tuesday, November 13, 2018 8:07:25 AM
The primary and secondary endpoints here are meaningless. Sorry. But they know it's true. FDA and CMS are not going to approve and pay for MWD... That's why this program has been delayed. They missed the most important 'primary' endpoint, didn't study it, amputations.
So what do they do? Tout other 'observations' and data points. NONE of which were powered for safety or efficacy claims.!!!!!
How do e know this?!?! Look at what they are focused on... NOT MWD... That's for sure.... Don't be duped. We are YEARS away from ANY approvals/contracts, R18 INCLUDED.
Kona Gold Beverages, Inc. Announces Strategic Initiatives and Corporate Direction Changes • KGKG • Aug 2, 2024 2:00 PM
POET and Luxshare Tech Expand Product Offerings for Artificial Intelligence Networks • POET • Aug 1, 2024 9:28 AM
Management Discusses Financial Filings of Global Arena Holding Inc., for 10-K 2023 and 10-Q, 1st Quarter 2024 • GAHC • Aug 1, 2024 9:14 AM
VAYK Announces LOI to Acquire $1 Million Home Service Company to Support Airbnb Business • VAYK • Aug 1, 2024 9:00 AM
Duane Forrester Joins INDEXR as SVP of Search • MONI • Jul 31, 2024 11:46 AM
Lingerie Fighting Championships Help Fulfill Death-Bed Promise With First Major Motion Picture • BOTY • Jul 31, 2024 9:00 AM